Skip to main content

Advertisement

SpringerLink
Log in

Liver-specific contrast agent-enhanced magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case

  • Case Report
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

We report a case of hepatocellular adenoma, focusing on the findings of liver-specific contrast agent-enhanced magnetic resonance imaging (MRI) and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). The patient was a 37-year-old woman, referred to us after contrast-enhanced computed tomography showed a homogeneous, poorly enhanced liver tumor, 2.8 cm in diameter. Magnetic resonance imaging showed a liver mass with significant fatty change. The tumor increased in size to 3.3 cm over 9 months of follow-up. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI revealed spotty enhancement in the hypointense tumor in the hepatobiliary phase. Subsequent FDG-PET showed increased uptake of FDG (maximum standardized uptake value 5.0), which suggested the possibility of malignancy. The patient underwent partial hepatectomy, and histological examination of the resected specimen revealed a tumor composed of hepatocyte-like cells with minimal cellular atypia and significant diffuse fatty change. Based on these findings, we diagnosed hepatocellular adenoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009;137:1698–705.

    Article  PubMed  Google Scholar 

  2. Hasegawa K, Kokudo N. Surgical treatment of hepatocellular carcinoma. Surg Today. 2009;39:833–43.

    Article  PubMed  Google Scholar 

  3. Lim AK, Patel N, Gedroyc WM, Blomley MJ, Hamilton G. Hepatocellular adenoma: diagnostic difficulties and novel imaging techniques. Br J Radiol. 2002;75:695–9.

    PubMed  CAS  Google Scholar 

  4. Ichikawa T, Federle MP, Grazioli L, Nalesnik M. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology. 2000;214:861–8.

    PubMed  CAS  Google Scholar 

  5. Delbeke D, Martin WH, Sandler MP, Chapman WC, Wright JK Jr, Pinson CW. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg. 1998;133:510–5.

    Article  PubMed  CAS  Google Scholar 

  6. Torizuka T, Tamaki N, Inokuma T, Magata Y, Sasayama S. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med. 1995;36:1811–7.

    PubMed  CAS  Google Scholar 

  7. Seo S, Hatano E, Higashi T, Hara T, Tada M. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res. 2007;13:427–3.

    Google Scholar 

  8. Zeng JP, Dong JH, Zhang WZ, Wang J, Pang XP. Hepatic angiomyolipoma: a clinical experience in diagnosis and treatment. Dig Dis Sci. 2010;55:3235–40.

    Article  PubMed  Google Scholar 

  9. Goodman ZD, Mikel UV, Lubbers PR, Ros PR, Langloss JM. Kupffer cells in hepatocellular adenomas. Am J Surg Pathol. 1987;11:191–6.

    Article  PubMed  CAS  Google Scholar 

  10. Beets-Tan RG, Van Engelshoven JM, Greve JW. Hepatic adenoma and focal nodular hyperplasia: MR findings with superparamagnetic iron oxide-enhanced MRI. Clin Imaging. 1998;22:211–5.

    Article  PubMed  CAS  Google Scholar 

  11. Kuwatsuru R, Brasch RC, Mühler A, Mathur A, Vexler VS, Rosenau W, et al. Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents. Radiology. 1997;202:131–8.

    PubMed  CAS  Google Scholar 

  12. Nakano K, Tsushima Y, Shibuya K, Miyazaki M, Koyama Y, Amanuma M, et al. A case of focal fatty liver, which showed hypointensity in the hepatobiliary phase of MR imaging with Gd-EOB-DTPA. Jpn J Clin Radiol. 2010;55:460–4 (in Japanese).

    Google Scholar 

  13. Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology. 2010;255:459–66.

    Article  PubMed  Google Scholar 

  14. Maeda A, Uesaka K, Matsunaga K, Hideyuki K, Noriyoshi F, Naoki M. Well differentiated hepatocellular carcinoma, 35 mm in diameter with remarkable fatty change, mimicking an angiomyolipoma on diagnostic images-a case report. Jpn J Gastroenterol Surg. 2005;38:1439–44 (in Japanese).

    Google Scholar 

  15. Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol. 2000;33:282–9.

    Article  PubMed  CAS  Google Scholar 

  16. Hustinx R, Paulus P, Jacquet N, Jerusalem G, Bury T, Rigo P. Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases. Ann Oncol. 1998;9:397–401.

    Article  PubMed  CAS  Google Scholar 

  17. Magini G, Farsad M, Frigerio M, Serra C, Colecchia A, Jovine E, et al. C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. Clin Nucl Med. 2009;34:659–65.

    Article  PubMed  Google Scholar 

  18. Patel PM, Alibazoglu H, Ali A, Fordham E, LaMonica G. “False-positive” uptake of FDG in a hepatic adenoma. Clin Nucl Med. 1997;22:490–1.

    Article  PubMed  CAS  Google Scholar 

  19. Yasuda S, Fujii H, Nakahara T, Nishiumi N, Takahashi W. 18F-FDG PET detection of colonic adenomas. J Nucl Med. 2001;42:989–92.

    PubMed  CAS  Google Scholar 

  20. Kubota K, Ito K, Morooka M, Mitsumoto T, Kurihara K, Yamashita H, et al. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints. Ann Nucl Med. 2009;23:783–91.

    Article  PubMed  Google Scholar 

  21. Nishizawa S, Inubushi M, Kido A, Miyagawa M, Inoue T, Shinohara K, et al. Incidence and characteristics of uterine leiomyomas with FDG uptake. Ann Nucl Med. 2008;22:803–10.

    Article  PubMed  Google Scholar 

  22. Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515–24.

    Article  PubMed  CAS  Google Scholar 

  23. Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J. Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol. 2007;13:2649–54.

    PubMed  CAS  Google Scholar 

  24. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007;46:740–8.

    Article  PubMed  CAS  Google Scholar 

  25. Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 2008;48:808–18.

    Article  PubMed  Google Scholar 

  26. Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50:481–9.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

Tatsuaki Sumiyoshi and co-authors have no conflict of interest.

Author information

Authors and Affiliations

  1. Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital, 1007 Shimo-Nagakubo, Sunto-Nagaizumi, Shizuoka, 411-8777, Japan

    Tatsuaki Sumiyoshi, Hideyuki Kanemoto, Teiichi Sugiura, Takashi Mizuno & Katsuhiko Uesaka

  2. Division of Diagnostic Radiology, Shizuoka Cancer Center Hospital, Shizuoka, Japan

    Michihisa Moriguchi & Kouiku Asakura

  3. Division of Pathology, Shizuoka Cancer Center Hospital, Shizuoka, Japan

    Keiko Sasaki

Authors
  1. Tatsuaki Sumiyoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michihisa Moriguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hideyuki Kanemoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kouiku Asakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keiko Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Teiichi Sugiura
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takashi Mizuno
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Katsuhiko Uesaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tatsuaki Sumiyoshi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sumiyoshi, T., Moriguchi, M., Kanemoto, H. et al. Liver-specific contrast agent-enhanced magnetic resonance and 18F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case. Surg Today 42, 200–204 (2012). https://doi.org/10.1007/s00595-011-0067-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-011-0067-7

Keywords

Search

Navigation